—  Posts another Quarter of Substantial Revenue Growth   — EL MONTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced financial results for the first quarter ended March 31, 2026, highlighted by substantial revenue growth over the comparable prior year period. First Quarter 2026 Financial HighlightsTotal revenues of $359.5 million, increased 32.2% year-over-year. Gross profit of $85.8 million, increased 34.7% year-over-year.Gross margin was 23.9%, compared to 23.4% in the first quarter of 2025. Net income of $38.1 million, compared to $27.1 million reported in the prior-year period.Net income margin was 10.6%, compared to 10.0% in the first quarter of 2025.Diluted EPS...

ATLANTA, May 07, 2026 (GLOBE NEWSWIRE) — Gray Media (NYSE: GTN) today announced its financial results for the first quarter that ended March 31, 2026. EXECUTIVE COMMENTARY Hilton Howell, Jr., Executive Chairman and CEO, commented, “Our first quarter 2026 results were solid, with Core Advertising exceeding our guidance and Political revenue at the high end of our guidance range. A recently resolved dispute with a distribution partner impacted our Net Retransmission Revenue for the quarter. With all scheduled 2026 retransmission negotiations now complete and the improvement in underlying MVPD subscriber trends, we now have visibility on our growth in Net Retransmission Revenue for full year 2026. While we are seeing some softness in core advertising in Q2, we are optimistic that, as the largest owner of top-rated local television...

Q1 2026 revenue of $22.5 million; GAAP basic EPS: $(0.10) Full year 2026 revenue guidance of $100.5 to $111.0 million affirmed NDA for F351 (hydronidone) for CHB-associated liver fibrosis submitted to China’s CDE in March 2026 Completed acquisition of Cullgen in an approximately $300 million all-stock transaction, expanding pipeline into inflammatory diseases and cancers First patient enrolled in Phase 2/3 trial evaluating ETUARY™ for radiation-induced lung injury, including immune-related pneumonitis SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) — Gyre Therapeutics, Inc. (Gyre, the Company or Gyre Therapeutics) (Nasdaq: GYRE), an innovative, commercial stage biopharmaceutical company with operations in the United States and China, today announced financial results for the first quarter ended March 31, 2026, and provided a business...

GRAND CAYMAN, Cayman Islands, May 07, 2026 (GLOBE NEWSWIRE) — Patria Investments Limited (Nasdaq:PAX) reported today its unaudited results for the first quarter ended March 31, 2026. The full detailed presentation of Patria’s first quarter 2026 results can be accessed on the Shareholders section of Patria’s website at https://ir.patria.com/. “We delivered a strong start to 2026, driven by continued fundraising momentum, meaningful growth in Fee-Earning AUM, and consistent investment performance across our platform,” said Alex Saigh, Chief Executive Officer of Patria. “We raised $2.1 billion in the quarter, grew Fee-Earning AUM to nearly $46 billion, and delivered 19% year-over-year growth in Fee Related Earnings, keeping us firmly on track to achieve our full year objectives. With increasing global and local investor engagement,...

HOUSTON, May 07, 2026 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“TRGP,” the “Company” or “Targa”) today reported first quarter 2026 results. First quarter 2026 net income attributable to Targa Resources Corp. was $480 million compared to $271 million for the first quarter of 2025. The Company reported adjusted earnings before interest, income taxes, depreciation and amortization, and other non-cash items (“adjusted EBITDA”)(1) of $1,403 million for the first quarter of 2026 compared to $1,179 million for the first quarter of 2025. HighlightsRecord adjusted EBITDA for the first quarter of $1.4 billion, an increase of 19% year-over-year Record Permian inlet volumes during the first quarter Record fractionation volumes during the first quarter Increasing full year 2026 adjusted EBITDA estimate to $5.7 billion to $5.9...

FREMONT, Calif., May 07, 2026 (GLOBE NEWSWIRE) — ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its first quarter ended March 31, 2026. “We are off to a solid start in 2026, with revenue of $231 million, up 34% year-over-year, and shipments of $241 million, up 54% year-over-year. Growth in the quarter was driven by strong performance in ECP and advanced packaging applications, reflecting increasing customer adoption of our differentiated technologies in high performance applications,” said Dr. David Wang, President and Chief Executive Officer of ACM. “This quarter, at Semicon China, we announced the ACM Planetary Family, a unified portfolio that reflects ACM’s status as a global, multi-product...

Delivers Another Record Quarter and Reaffirms Full Year 2026 Guidance First Quarter 2026 Highlights1Revenues of $385.2 million (8.6% growth year-over-year) Net income of $2.2 million (0.6% margin); Diluted net income per share of $0.01 Adjusted EBITDA of $105.3 million (27.3% margin) Adjusted Net Income of $45.1 million; Adjusted Diluted Earnings Per Share of $0.26 Cash Flows from Operations of $49.4 million Subsequent to the end of the quarter, voluntary debt prepayment of $25 million made on May 6, in addition to $25 million prepayment made on February 27 $19.5 million in shares repurchased under $100 million share repurchase program Reaffirming full year 2026 guidance ranges3ATLANTA, May 07, 2026 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a global software and data company, today announced financial results...

Q1 2026 EPS Exceeded Guidance Range, Both Revenue and GM At the High End of Guidance Range Issued on February 12, 2026Company Q2 2026 Guidance: Revenues to Increase 10.0% to 13.0% QoQ, Gross Margin is Expected to be around 32%. Profit per Diluted ADS to be 8.6 Cents to 10.3 CentsQ1 2026 revenues were $199.0 million, a slight sequential decline of 2.0%, reaching the high end of guidance range of 2.0% to 6.0% decrease QoQ Q1 GM reached 30.4%, at the high end of guidance of flat to slightly down from 30.4% in the previous quarter Q1 2026 after-tax profit was $8.0 million, or 4.6 cents per diluted ADS, exceeding the guidance range of 2.0 to 4.0 cents Himax Q2 2026 revenues to increase 10.0% to 13.0% QoQ. GM to be around 32%. Profit per diluted ADS to be in the range of 8.6 cents to 10.3 cents Himax expects upward momentum through the remainder...

Phase 1 clinical trial of SL-325 enrollment complete; data expected in the second quarter of 2026 – Phase 2 clinical trial of SL-325 in patients with Crohn’s disease expected to initiate in the third quarter of 2026 –AUSTIN, Texas and DURHAM, N.C., May 07, 2026 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potential first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today reported financial results for the first quarter ended March 31, 2026 and provided recent business highlights. “We are pleased to have completed enrollment in our Phase 1 clinical trial of SL-325, and are looking forward to sharing a comprehensive data set on all single...

BOSTON HEIGHTS, Ohio, May 07, 2026 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, reported first quarter results for the period ended March 31, 2026. First Quarter 2026 HighlightsCompared to the first quarter of 2025:Net revenue increased 0.9% to $314 million Gross margin decreased 1.0% to $114 million Selling, general and administrative expenses increased 1.9% to $112 million Net and comprehensive income decreased 54.5% to $2 million Adjusted EBITDA decreased 3.1% to $18 million Comparable Delivered Sales(1) decreased 1.7% Comparable Written Sales(2) decreased 5.7%John Reed, Co-Founder and Chief Executive Officer, said:“We achieved the highest first-quarter net revenue in Arhaus...